The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases

Nutrients. 2024 Jan 19;16(2):308. doi: 10.3390/nu16020308.

Abstract

Many researchers propose manipulating microbiota to prevent and treat related diseases. The brain-gut axis is an object that remains the target of modern research, and it is not without reason that many researchers enrich it with microbiota and diet in its name. Numerous connections and mutual correlations have become the basis for seeking answers to many questions related to pathology as well as human physiology. Disorders of this homeostasis as well as dysbiosis itself accompany neurodegenerative diseases such as Alzheimer's and Parkinson's. Heavily dependent on external factors, modulation of the gut microbiome represents an opportunity to advance the treatment of neurodegenerative diseases. Probiotic interventions, synbiotic interventions, or fecal transplantation can undoubtedly support the biotherapeutic process. A special role is played by diet, which provides metabolites that directly affect the body and the microbiota. A holistic view of the human organism is therefore essential.

Keywords: gut-brain axis; microbiota; neurodegenerative diseases.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease*
  • Brain
  • Diet
  • Dysbiosis
  • Gastrointestinal Microbiome*
  • Humans
  • Microbiota*
  • Parkinson Disease* / therapy

Grants and funding

This research received no external funding.